Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$312,944
-$91,925 QoQ
Shares Held
2,477
-14.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,624
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesapeake Wealth Management holds $12,931,041 across 7 Drug Manufacturers - General names. GILD ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,031 | $3,635,471 | |
| 2 | ABBV |
AbbVie Inc.
|
14,357 | $3,612,794 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,024 | $1,930,584 | |
| 4 | JNJ |
Johnson & Johnson
|
7,575 | $1,923,822 | |
| 5 | AMGN |
Amgen Inc
|
3,188 | $1,154,437 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,265 | $360,989 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,477 | $312,944 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,944 | 2,477 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $404,869 | 2,905 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $356,559 | 2,905 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $265,068 | 2,388 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $259,214 | 2,338 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $261,972 | 2,338 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $430,998 | 4,666 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $391,197 | 4,666 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $320,134 | 4,666 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $344,568 | 4,704 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $377,992 | 4,666 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $349,670 | 4,666 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $366,544 | 4,756 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $394,605 | 4,756 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $411,822 | 4,797 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $295,926 | 4,797 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $296,502 | 4,797 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $285,181 | 4,797 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $357,168 | 4,919 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $325,920 | 4,666 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $321,300 | 4,666 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $301,563 | 4,666 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $291,416 | 5,002 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $316,076 | 5,002 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $384,853 | 5,002 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $373,949 | 5,002 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||